A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)

Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
10/2001
10/16/2001	US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease
10/16/2001	US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds
10/16/2001	US6303600 Substituted azabicyclic compounds
10/16/2001	US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects
10/16/2001	US6303321 Methods for diagnosing sepsis
10/16/2001	US6303314 T-cell receptor Vβ-Dβ-Jβ sequence and methods for its detection
10/16/2001	US6303121 Method of using human receptor protein 4-1BB
10/16/2001	CA2098302C Medicaments
10/16/2001	CA2073351C Lysozyme dimers and method of preparing them
10/16/2001	CA2036977C Imidazopyridazines, their production and use
10/16/2001	CA2015470C Fluorinated arachidonic acid derivatives
10/11/2001	WO2001075170A1 A functional assay of high-density lipoprotein
10/11/2001	WO2001075168A1 Control of a gene induced by oxidized lipids in human artery wall cells
10/11/2001	WO2001075081A1 Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase
10/11/2001	WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS
10/11/2001	WO2001074903A2 CD20/IgE-RECEPTOR LIKE MOLECULES AND USES THEREOF
10/11/2001	WO2001074900A2 Nuclear factor kb inducing factor
10/11/2001	WO2001074896A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	WO2001074837A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
10/11/2001	WO2001074806A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001	WO2001074781A1 Chemical complex comprising a substituted pyridine carboxy derivative and a glucosaminoglycan
10/11/2001	WO2001074780A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001	WO2001074769A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/11/2001	WO2001074763A1 Aryl and heteroaryl sulfonates
10/11/2001	WO2001074506A1 Extrusion die
10/11/2001	WO2001074400A1 Transporters and drug delivery system by using the same
10/11/2001	WO2001074379A2 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	WO2001074369A1 Divided dose therapies with vascular damaging activity
10/11/2001	WO2001074367A1 Pharmaceutical composition based on a non-steroid anti-inflammatory agent
10/11/2001	WO2001074362A1 Inhibition of cyclooxygenase-2 activity
10/11/2001	WO2001074360A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
10/11/2001	WO2001074340A2 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
10/11/2001	WO2001074337A1 System for transporting active substances in a biological system
10/11/2001	WO2001074332A1 Pharmaceutical preparations and their manufacture
10/11/2001	WO2001048190A8 Therapeutic uses of lna-modified oligonucleotides
10/11/2001	WO2001027119A3 Substance library containing bicyclic imidazo-5-yl-amines and/or bicyclic imidazo-3-yl-amines
10/11/2001	WO2001025269A3 Human g-protein coupled receptor
10/11/2001	WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001	WO2001021587A3 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors
10/11/2001	WO2001021202A3 Treatment of chronic inflammatory disease by inhibiting sub-groups of activated t-cells
10/11/2001	WO2001019826A3 Triazolopyrimidine derivatives
10/11/2001	WO2001012264A3 Topical azathioprine for the treatment of oral autoimmune diseases
10/11/2001	WO2001007470A3 Human nervous system-associated proteins
10/11/2001	WO2000062736A3 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion
10/11/2001	WO2000050633A9 Method for cloning signal transduction intermediates
10/11/2001	WO2000042429A3 In vitro model for gastrointestinal inflammation
10/11/2001	US20010029304 Cyclopentane heptan (ENE)OIC acid, 2-heteroarylalkenyl derivatives as therapeutic agents
10/11/2001	US20010029269 Non-steroidal antiinflammatory agent
10/11/2001	US20010029264 In mixture with vitamin e, dimethylisosorbide, citric acid and polyoxyethylene glycol
10/11/2001	US20010029250 Antiinflammatory agents; anticarcinogenic agents
10/11/2001	US20010028880 Administering protein c
10/11/2001	EP1145001A3 (in vitro) model for gastrointestinal inflammation
10/11/2001	DE10015866A1 Aryl- und Heteroarylsulfonate Aryl and Heteroarylsulfonate
10/11/2001	CA2404965A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof
10/11/2001	CA2404545A1 Aryl and heteroaryl sulfonates
10/11/2001	CA2404526A1 Protein amf-1 to amf-10 and nucleic acids encoding the same
10/11/2001	CA2404519A1 Wnt-7b-like polypeptides and nucleic acids encoding same
10/11/2001	CA2404484A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis
10/11/2001	CA2404367A1 Pharmaceutical preparations and their manufacture
10/11/2001	CA2404358A1 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug
10/11/2001	CA2404350A1 Control of a gene induced by oxidized lipids in human artery wall cells
10/11/2001	CA2404074A1 Human polynucleotides, polypeptides, and antibodies
10/11/2001	CA2403885A1 Chemical complex comprising a pyridine carboxy derivative and an h2 histamine receptor antagonist
10/11/2001	CA2403735A1 Methods for identifying compounds useful for inhibiting geranylgeranyl diphosphate synthase
10/11/2001	CA2403600A1 Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
10/11/2001	CA2402586A1 Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
10/11/2001	CA2402078A1 Divided dose therapies with vascular damaging activity
10/11/2001	CA2401948A1 Cd20/ige-receptor like molecules and uses thereof
10/11/2001	CA2401854A1 Therapeutic combinations of antihypertensive and antiangiogenic agents
10/11/2001	CA2401137A1 Pharmaceutically active pyrrolidine derivatives as bax inhibitors
10/10/2001	EP1142910A1 Inhibitors for the formation of soluble human CD23
10/10/2001	EP1142890A1 Aminopyrazole derivatives
10/10/2001	EP1142889A1 Pyrazole derivatives as anti-inflammatory/analgesic agents
10/10/2001	EP1142881A1 Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives
10/10/2001	EP1142877A1 2-oxoquinoline compounds and medicinal uses thereof
10/10/2001	EP1142867A2 Cell adhesion inhibitors
10/10/2001	EP1142566A1 Compositions for ophtalmic use containing cyclosporin, hyaluronic acid and polysorbate
10/10/2001	EP1141728A1 Kidney disease detection and treatment
10/10/2001	EP1141720A1 Detection of preactivated phagocytes
10/10/2001	EP1141342A2 Use of plus-strand synthesis elements in retroviral vectors
10/10/2001	EP1141332A1 Human cyclic nucleotide pdes
10/10/2001	EP1141325A1 Ikk3 kinase
10/10/2001	EP1141296A2 Interferon-epsilon
10/10/2001	EP1141288A2 Lymphocytic membrane proteins
10/10/2001	EP1141286A1 Cytokine receptor chain
10/10/2001	EP1141278A2 Therapeutic phosphodiesterase inhibitors
10/10/2001	EP1141274A2 Soluble receptor br43x2 and methods of using them for therapy
10/10/2001	EP1141240A1 Use of cd40 engagement to alter t cell receptor usage
10/10/2001	EP1141235A2 (bifidobacterium) in the treatment of inflammatory disease
10/10/2001	EP1141028A2 Human monoclonal antibodies to ctla-4
10/10/2001	EP1141027A1 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders
10/10/2001	EP1141011A2 Compounds and methods to inhibit or augment an inflammatory response
10/10/2001	EP1140989A1 Alpha(v) beta(6) integrin inhibitors
10/10/2001	EP1140984A1 Selective inhibitors of mmp-12
10/10/2001	EP1140970A1 47 human secreted proteins
10/10/2001	EP1140969A1 Connective tissue growth factor fragments and methods and uses thereof
10/10/2001	EP1140966A1 Acid stable backbone modified end-blocked nucleic acids and therapeutic uses thereof
10/10/2001	EP1140964A2 Connective tissue growth factor fragments and methods and uses thereof

1 ... 982 983 984 985 986 987 988 989 990 991 992 993 994 995 996 997 998 999 1000 1001 1002 ... 1272